Metraipolis › archive › dc_84cbb7e69c55

Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa: a systematic review and… — Europe PMC PMID:42812940

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42812940
DOI
10.1093/skinhd/vzag102
License (as archived)
solo-consultazione
Archived
2026-10-18T08:25:19.172Z
SHA-256 of the archived text
3b40526b3f9b9dedab218ef9921b3a511d6fffd0f7436e52f22f215571991974
Stable URL of this page
https://metraipolis.com/documento/dc_84cbb7e69c55

How to cite

Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa: a systematic review and… — Europe PMC PMID:42812940 — Europe PMC (en), https://europepmc.org/article/MED/42812940 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84cbb7e69c55 (Metraipolis archive dc_84cbb7e69c55, sha256 3b40526b3f9b9dedab218ef9921b3a511d6fffd0f7436e52f22f215571991974)
BibTeX
@misc{dc84cbb7e69c55,
  title = {Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa: a systematic review and… — Europe PMC PMID:42812940},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42812940},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84cbb7e69c55; sha256 3b40526b3f9b9dedab218ef9921b3a511d6fffd0f7436e52f22f215571991974},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42812940. Agents can read the archived copy with the MCP tool read_document.